Close to 300 heart and stroke therapies under development
According to PhRMA, there are currently 277 medications either in clinical trials or under review by the FDA for treating heart disease and stroke, the two leading causes of death in the U.S.
According to PhRMA, there are currently 277 medications either in clinical trials or under review by the FDA for treating heart disease and stroke, the two leading causes of death in the U.S. A new report released by the group said that 30 drugs are in development for heart failure, 31 for hypertension, 19 for myocardial infarction, and 19 for stroke. In addition, PhRMA said that many of the new therapies use cutting-edge technologies such as human stem cells that are used to restore cardiac function by forming new heart muscle and a vaccine that prevents the transfer of "good" cholesterol to "bad" cholesterol. The report can be found on-line at
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
